Marine-Derived 2-Aminoimidazolone Alkaloids. Leucettamine B-Related Polyandrocarpamines Inhibit Mammalian and Protozoan DYRK & CLK Kinases.

Marine-Derived 2-Aminoimidazolone Alkaloids. Leucettamine B-Related Polyandrocarpamines Inhibit Mammalian and Protozoan DYRK & CLK Kinases.
复制标题

DOI:
10.3390/md15100316
复制
发表时间:
2017-10-17
期刊:
影响因子:
5.4
通讯作者:
Meijer L
Meijer L
中科院分区:
医学2区
文献类型:
--
作者:
Loaëc N;Attanasio E;Villiers B;Durieu E;Tahtouh T;Cam M;Davis RA;Alencar A;Roué M;Bourguet-Kondracki ML;Proksch P;Limanton E;Guiheneuf S;Carreaux F;Bazureau JP;Klautau M;Meijer L

文献摘要

参考文献

被引文献

相似文献

A large diversity of 2-aminoimidazolone alkaloids is produced by various marine invertebrates, especially by the marine Calcareous sponges Leucetta and Clathrina. The phylogeny of these sponges and the wide scope of 2-aminoimidazolone alkaloids they produce are reviewed in this article. The origin (invertebrate cells, associated microorganisms, or filtered plankton), physiological functions, and natural molecular targets of these alkaloids are largely unknown. Following the identification of leucettamine B as an inhibitor of selected protein kinases, we synthesized a family of analogues, collectively named leucettines, as potent inhibitors of DYRKs (dual-specificity, tyrosine phosphorylation regulated kinases) and CLKs (cdc2-like kinases) and potential pharmacological leads for the treatment of several diseases, including Alzheimer’s disease and Down syndrome. We assembled a small library of marine sponge- and ascidian-derived 2-aminoimidazolone alkaloids, along with several synthetic analogues, and tested them on a panel of mammalian and protozoan kinases. Polyandrocarpamines A and B were found to be potent and selective inhibitors of DYRKs and CLKs. They inhibited cyclin D1 phosphorylation on a DYRK1A phosphosite in cultured cells. 2-Aminoimidazolones thus represent a promising chemical scaffold for the design of potential therapeutic drug candidates acting as specific inhibitors of disease-relevant kinases, and possibly other disease-relevant targets.
DOI: 10.1016/s0040-4039(00)86943-9
发表时间: 1982-01-01
影响因子: 1.8
作者:
CIMINO, G;DEROSA, S;SODANO, G
通讯作者: SODANO, G
DOI: 10.1124/mol.113.090837
发表时间: 2014-03-01
影响因子: 3.6
作者:
Fant, Xavier;Durieu, Emilie;Meijer, Laurent
通讯作者: Meijer, Laurent
DOI: 10.1016/s0040-4020(02)00228-4
发表时间: 2002-04-15
期刊: TETRAHEDRON
影响因子: 2.1
作者:
Davis, RA;Aalbersberg, W;Ireland, CM
通讯作者: Ireland, CM
DOI: 10.1021/np50078a004
发表时间: 1991-11-01
影响因子: 5.1
作者:
ALVI, KA;CREWS, P;LOUGHHEAD, DG
通讯作者: LOUGHHEAD, DG
DOI: 10.1002/mrc.3958
发表时间: 2013-06-01
影响因子: 2
作者:
Baron, Paul S.;Neve, Juliette E.;Davis, Rohan A.
通讯作者: Davis, Rohan A.